EYEN
Price
$0.99
Change
-$0.12 (-10.81%)
Updated
Apr 4, 03:53 PM (EDT)
Capitalization
2.32M
40 days until earnings call
HALO
Price
$59.90
Change
-$2.02 (-3.26%)
Updated
Apr 4, 04:24 PM (EDT)
Capitalization
7.65B
39 days until earnings call
Ad is loading...

EYEN vs HALO

Header iconEYEN vs HALO Comparison
Open Charts EYEN vs HALOBanner chart's image
Eyenovia
Price$0.99
Change-$0.12 (-10.81%)
Volume$350
Capitalization2.32M
Halozyme Therapeutics
Price$59.90
Change-$2.02 (-3.26%)
Volume$2.9K
Capitalization7.65B
EYEN vs HALO Comparison Chart
Loading...
EYEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HALO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EYEN vs. HALO commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EYEN is a Hold and HALO is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (EYEN: $1.11 vs. HALO: $61.92)
Brand notoriety: EYEN and HALO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EYEN: 8% vs. HALO: 139%
Market capitalization -- EYEN: $2.32M vs. HALO: $7.65B
EYEN [@Biotechnology] is valued at $2.32M. HALO’s [@Biotechnology] market capitalization is $7.65B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EYEN’s FA Score shows that 1 FA rating(s) are green whileHALO’s FA Score has 2 green FA rating(s).

  • EYEN’s FA Score: 1 green, 4 red.
  • HALO’s FA Score: 2 green, 3 red.
According to our system of comparison, HALO is a better buy in the long-term than EYEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EYEN’s TA Score shows that 4 TA indicator(s) are bullish while HALO’s TA Score has 3 bullish TA indicator(s).

  • EYEN’s TA Score: 4 bullish, 3 bearish.
  • HALO’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, EYEN is a better buy in the short-term than HALO.

Price Growth

EYEN (@Biotechnology) experienced а -11.90% price change this week, while HALO (@Biotechnology) price change was -3.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -11.08%. For the same industry, the average monthly price growth was -16.97%, and the average quarterly price growth was -18.77%.

Reported Earning Dates

EYEN is expected to report earnings on May 14, 2025.

HALO is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-11.08% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HALO($7.65B) has a higher market cap than EYEN($2.32M). HALO YTD gains are higher at: 29.513 vs. EYEN (-90.497). HALO has higher annual earnings (EBITDA): 657M vs. EYEN (-34.09M). HALO has more cash in the bank: 596M vs. EYEN (26.7M). EYEN has less debt than HALO: EYEN (13M) vs HALO (1.51B). HALO has higher revenues than EYEN: HALO (1.02B) vs EYEN (31.8K).
EYENHALOEYEN / HALO
Capitalization2.32M7.65B0%
EBITDA-34.09M657M-5%
Gain YTD-90.49729.513-307%
P/E RatioN/A18.37-
Revenue31.8K1.02B0%
Total Cash26.7M596M4%
Total Debt13M1.51B1%
FUNDAMENTALS RATINGS
EYEN vs HALO: Fundamental Ratings
EYEN
HALO
OUTLOOK RATING
1..100
183
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
81
Overvalued
PROFIT vs RISK RATING
1..100
10022
SMR RATING
1..100
10011
PRICE GROWTH RATING
1..100
9739
P/E GROWTH RATING
1..100
10052
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EYEN's Valuation (26) in the Pharmaceuticals Major industry is somewhat better than the same rating for HALO (81) in the Biotechnology industry. This means that EYEN’s stock grew somewhat faster than HALO’s over the last 12 months.

HALO's Profit vs Risk Rating (22) in the Biotechnology industry is significantly better than the same rating for EYEN (100) in the Pharmaceuticals Major industry. This means that HALO’s stock grew significantly faster than EYEN’s over the last 12 months.

HALO's SMR Rating (11) in the Biotechnology industry is significantly better than the same rating for EYEN (100) in the Pharmaceuticals Major industry. This means that HALO’s stock grew significantly faster than EYEN’s over the last 12 months.

HALO's Price Growth Rating (39) in the Biotechnology industry is somewhat better than the same rating for EYEN (97) in the Pharmaceuticals Major industry. This means that HALO’s stock grew somewhat faster than EYEN’s over the last 12 months.

HALO's P/E Growth Rating (52) in the Biotechnology industry is somewhat better than the same rating for EYEN (100) in the Pharmaceuticals Major industry. This means that HALO’s stock grew somewhat faster than EYEN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EYENHALO
RSI
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
56%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
67%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
67%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
69%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 15 days ago
77%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 4 days ago
67%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
63%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Ad is loading...
EYEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HALO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DFAX25.84-0.51
-1.94%
Dimensional World ex US Core Eq 2 ETF
SLVP14.66-0.31
-2.07%
iShares MSCI Global Silver&Mtls Mnrs ETF
BCX9.01-0.37
-3.94%
Blackrock Resources & Commodities Strategy Trust
SSPY75.50-3.45
-4.37%
Stratified LargeCap Index ETF
CAFG22.87-1.37
-5.65%
Pacer US Small Cap Cash Cows Gr Ldrs ETF